Shinva Medical Instrument Co.,Ltd. (SHA:600587)
China flag China · Delayed Price · Currency is CNY
12.25
-0.23 (-1.84%)
Sep 11, 2026, 3:00 PM CST

Shinva Medical Instrument Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
9,8419,4719,8649,9049,0729,343
Other Revenue
264.98264.98156.13108210.16139.3
10,1069,73610,02110,0129,2829,482
Revenue Growth
5.01%-2.84%0.09%7.87%-2.11%3.62%
Cost of Revenue
7,6567,3647,4617,3946,8637,200
Gross Profit
2,4512,3722,5592,6182,4192,282
Selling, General & Admin
1,3461,3001,2911,3441,3491,324
Research & Development
418.5442.03436.08443.37401.27295.98
Other Operating Expenses
40.615.0221.6476.9967.6259.36
Operating Expenses
1,8391,7921,8181,9481,8461,714
Operating Income
611.54580.21741.93670.31572.27567.33
Interest Expense
-41.41-41.41-44.79-47.07-56.93-76.26
Interest & Investment Income
5.4357.5595.57110.9661.75126.94
Currency Exchange Gain (Loss)
-1.03-1.034.147.5410.37-0.99
Other Non Operating Income (Expenses)
-42.74-16.38-29.19-9.44-4.17-12.03
EBT Excluding Unusual Items
531.8578.93767.65732.3583.29604.99
Impairment of Goodwill
---15.22-11.49--
Gain (Loss) on Sale of Investments
-24.41--12.54-57.2160.71
Gain (Loss) on Sale of Assets
-1.72-2.75-1.514.40.48-0.35
Asset Writedown
-24.55-0.05--0.73--0.62
Legal Settlements
-0.87-0.87----0.57
Other Unusual Items
15.8615.8644.741.5749.5353.87
Pretax Income
496.1591.12795.66738.58576.09718.03
Income Tax Expense
69.0562.99103.7662.0849.18162.01
Earnings From Continuing Operations
427.06528.13691.9676.5526.91556.02
Minority Interest in Earnings
-1.16-1.8-0.29-22.5-26.840.47
Net Income
425.9526.34691.61654500.07556.49
Net Income to Common
425.9526.34691.61654500.07556.49
Net Income Growth
-28.19%-23.90%5.75%30.78%-10.14%137.68%
Shares Outstanding (Basic)
607605607595529528
Shares Outstanding (Diluted)
607605607600529528
Shares Change
-8.49%-0.28%1.11%13.53%0.08%0.64%
EPS (Basic)
0.700.871.141.100.951.05
EPS (Diluted)
0.700.871.141.090.951.05
EPS Growth
-21.53%-23.68%4.59%15.20%-10.21%136.17%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
550.76319.0929.85494.34140.471,128
Free Cash Flow Per Share
0.910.530.050.820.272.14
Dividend Per Share
0.3500.3500.2500.3850.1150.115
Dividend Growth
40.00%40.00%-35.00%233.28%0%50.07%
Gross Margin
24.25%24.36%25.54%26.15%26.06%24.06%
Operating Margin
6.05%5.96%7.40%6.69%6.17%5.98%
Profit Margin
4.21%5.41%6.90%6.53%5.39%5.87%
Free Cash Flow Margin
5.45%3.28%0.30%4.94%1.51%11.90%
EBITDA
840.75792.97934.83857.33761.5744.07
EBITDA Margin
8.32%8.14%9.33%8.56%8.20%7.85%
D&A For EBITDA
229.2212.77192.9187.03189.23176.74
EBIT
611.54580.21741.93670.31572.27567.33
EBIT Margin
6.05%5.96%7.40%6.69%6.17%5.98%
Effective Tax Rate
13.92%10.66%13.04%8.40%8.54%22.56%
Revenue as Reported
9,7369,73610,02110,0129,2829,482
Advertising Expenses
-17.3620.6524.1922.6638.05